Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neonatal Hyperglycaemia pilot trial
ACTRN12606000270516Phase 4Completed
- Sponsor
- Dr Jane Alsweiler
- Start
- Jul 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of human insulin in neonatal hyperglycemia (2 arms), sponsored by Dr Jane Alsweiler. Primary endpoint: Lower leg growth rate. Started Jul 2005; status: completed.
02
Drugs
human insulin
03
Conditions
neonatal hyperglycemia
Beyond the preview
Go deeper on ACTRN12606000270516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000270516.